Profile
Dr. Mark B. Abelson, MD, is a Professor-Ophthalmology at Harvard Medical School and a Senior Clinical Scientist at The Schepens Eye Research Institute, Inc. Dr. Abelson was previously employed as a Treasurer & Chief Scientific Officer by Ora, Inc. He also served on the board at Nicox Ophthalmics, Inc.
Mark Barry Abelson active positions
| Companies | Position | Start |
|---|---|---|
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-03-24 |
The Schepens Eye Research Institute, Inc.
The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical ophthalmology research enterprise | Corporate Officer/Principal | 2012-12-16 |
Former positions of Mark Barry Abelson
| Companies | Position | End |
|---|---|---|
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Founder | 2020-02-29 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology pharmaceutical products | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology pharmaceutical products | Health Technology |
The Schepens Eye Research Institute, Inc.
The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical ophthalmology research enterprise | Commercial Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ora, Inc.
Ora, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products and provides clinical research services | Health Technology |
- Stock Market
- Insiders
- Mark Barry Abelson
















